Molecular Partners Cuts Costs, Extends Cash Runway into 2028 While Advancing Key Clinical Programs Molecular Partners AG (NASDAQ: MOLN) announced a strategic reduction in workforce as part of a broader operational efficiency plan, allowing the company to exte

#MOLN Cuts Costs, Extends Cash Runway into 2028 While Advancing Key Clinical Programs
#MolecularPartners
prismmarketview.com/molecular-pa...